免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

FDA 510(k)

TELIGEN 系统外周运动神经刺激指示

K号: K223438 · 2023-02-10

决定日期2023-02-10
产品代码PDQ
咨询委员会医疗设备监管文本描述翻译如下: 关于[公司/产品名称]的监管信息: - 美国食品药品监督管理局(FDA)批准号:[510(k)编号] - 预市场批准(PMA)申请号:[PMA编号] - 临床试验注册号(NCT):[NCT编号] - 医学文献标识符(PMID):[PMID编号] - 产品标识符:[标识符] - 相关政策:医疗监管政策v1 - 更多信息请访问:[URL] 请注意,以上翻译保留了公司/产品名称、FDA、510(k)、PMA、NCT、PMID、标识符和URL。
决定实质等同

器械摘要

TELIGEN System Peripheral Motor Nerve Stimulation Indications is the device name listed in this FDA 510(k) record. The listed applicant is Medos International SARL. It received FDA 510(k) clearance on 2023-02-10 under 510(k) number K223438. The device is classified under product code PDQ. It was reviewed by the EN advisory panel. FDA Decision: Substantially Equivalent.

常见问题

What is the TELIGEN System Peripheral Motor Nerve Stimulation Indications?

TELIGEN System Peripheral Motor Nerve Stimulation Indications is a medical device that received FDA 510(k) clearance on 2023-02-10. The listed applicant is Medos International SARL. The 510(k) number is K223438.

When did TELIGEN System Peripheral Motor Nerve Stimulation Indications receive FDA 510(k) clearance?

TELIGEN System Peripheral Motor Nerve Stimulation Indications received FDA 510(k) clearance on 2023-02-10, under 510(k) number K223438.

Who is the listed applicant for TELIGEN System Peripheral Motor Nerve Stimulation Indications?

The FDA 510(k) record lists Medos International SARL as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for TELIGEN System Peripheral Motor Nerve Stimulation Indications?

The FDA product code for TELIGEN System Peripheral Motor Nerve Stimulation Indications is PDQ.

相关临床试验

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

列明Medos International SARL为申报人的其他记录

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

查看所有 75 个设备 →

相关器械(代码:PDQ)

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息,请务必参考官方记录。

↑